Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.
Luo H, Feng Y, Wang F, Lin Z, Huang J, Li Q, Wang X, Liu X, Zhai X, Gao Q, Li L, Zhang Y, Wen J, Zhang L, Niu T, Zheng Y.
Luo H, et al. Among authors: zhang l, zhang y.
Cancer Lett. 2023 Jul 1;565:216218. doi: 10.1016/j.canlet.2023.216218. Epub 2023 May 4.
Cancer Lett. 2023.
PMID: 37149018
Free article.